FMN may protect against ischemic stroke by downregulating the Bax/Bcl-2 ratio, activating PI3K/AKT and anti-apoptosis, and reducing the TNF-α level (Li et al., 2014; Liang et al., 2014). The gene discussed is FMN1; the disease is ischemic stroke.